Report Overview
Peptide CDMO services refer to peptide drug development and manufacturing outsourcing services. Polypeptides are short-chain proteins composed of amino acids and have a wide range of biological activities and pharmacological applications.
The global Peptide Cdmo Services market size was estimated at USD 3184.25 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Peptide Cdmo Services market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Peptide Cdmo Services market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Peptide Cdmo Services market.
Global Peptide Cdmo Services Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Gliead
Boehringer Ingelheim
Vertex
Mirati Therapeutics
AMPAC
Pfizer
Polypeptide
Bachem
Merck
Asymchem
Zhejiang Jiuzhou Pharmaceutical
Sinopep
Frontier Biotechnologies
JYMed
Chengdu Shengnuo Biotechnology
Shanghai Soho-Yiming Pharmaceuticals
Chinese Peptide Company
Ambio Pharmaceuticals
Zhejiang Peptites Biotech
STA Pharmaceutical
Market Segmentation (by Type)
Small Molecule CDMO
Macro-molecular CDMO
Market Segmentation (by Application)
Clinical Treatment
Medical Research
Commercial Production
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Peptide Cdmo Services Market
Overview of the regional outlook of the Peptide Cdmo Services Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Peptide Cdmo Services Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Peptide Cdmo Services, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Peptide Cdmo Services
1.2 Key Market Segments
1.2.1 Peptide Cdmo Services Segment by Type
1.2.2 Peptide Cdmo Services Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Peptide Cdmo Services Market Overview
2.1 Global Market Overview
2.1.1 Global Peptide Cdmo Services Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Peptide Cdmo Services Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Peptide Cdmo Services Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Peptide Cdmo Services Product Life Cycle
3.3 Global Peptide Cdmo Services Sales by Manufacturers (2020-2025)
3.4 Global Peptide Cdmo Services Revenue Market Share by Manufacturers (2020-2025)
3.5 Peptide Cdmo Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Peptide Cdmo Services Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Peptide Cdmo Services Market Competitive Situation and Trends
3.8.1 Peptide Cdmo Services Market Concentration Rate
3.8.2 Global 5 and 10 Largest Peptide Cdmo Services Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Peptide Cdmo Services Industry Chain Analysis
4.1 Peptide Cdmo Services Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Peptide Cdmo Services Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Peptide Cdmo Services Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Peptide Cdmo Services Market
5.7 ESG Ratings of Leading Companies
6 Peptide Cdmo Services Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Peptide Cdmo Services Sales Market Share by Type (2020-2025)
6.3 Global Peptide Cdmo Services Market Size Market Share by Type (2020-2025)
6.4 Global Peptide Cdmo Services Price by Type (2020-2025)
7 Peptide Cdmo Services Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Peptide Cdmo Services Market Sales by Application (2020-2025)
7.3 Global Peptide Cdmo Services Market Size (M USD) by Application (2020-2025)
7.4 Global Peptide Cdmo Services Sales Growth Rate by Application (2020-2025)
8 Peptide Cdmo Services Market Sales by Region
8.1 Global Peptide Cdmo Services Sales by Region
8.1.1 Global Peptide Cdmo Services Sales by Region
8.1.2 Global Peptide Cdmo Services Sales Market Share by Region
8.2 Global Peptide Cdmo Services Market Size by Region
8.2.1 Global Peptide Cdmo Services Market Size by Region
8.2.2 Global Peptide Cdmo Services Market Size Market Share by Region
8.3 North America
8.3.1 North America Peptide Cdmo Services Sales by Country
8.3.2 North America Peptide Cdmo Services Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Peptide Cdmo Services Sales by Country
8.4.2 Europe Peptide Cdmo Services Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Peptide Cdmo Services Sales by Region
8.5.2 Asia Pacific Peptide Cdmo Services Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Peptide Cdmo Services Sales by Country
8.6.2 South America Peptide Cdmo Services Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Peptide Cdmo Services Sales by Region
8.7.2 Middle East and Africa Peptide Cdmo Services Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Peptide Cdmo Services Market Production by Region
9.1 Global Production of Peptide Cdmo Services by Region(2020-2025)
9.2 Global Peptide Cdmo Services Revenue Market Share by Region (2020-2025)
9.3 Global Peptide Cdmo Services Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Peptide Cdmo Services Production
9.4.1 North America Peptide Cdmo Services Production Growth Rate (2020-2025)
9.4.2 North America Peptide Cdmo Services Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Peptide Cdmo Services Production
9.5.1 Europe Peptide Cdmo Services Production Growth Rate (2020-2025)
9.5.2 Europe Peptide Cdmo Services Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Peptide Cdmo Services Production (2020-2025)
9.6.1 Japan Peptide Cdmo Services Production Growth Rate (2020-2025)
9.6.2 Japan Peptide Cdmo Services Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Peptide Cdmo Services Production (2020-2025)
9.7.1 China Peptide Cdmo Services Production Growth Rate (2020-2025)
9.7.2 China Peptide Cdmo Services Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 Gliead
10.1.1 Gliead Basic Information
10.1.2 Gliead Peptide Cdmo Services Product Overview
10.1.3 Gliead Peptide Cdmo Services Product Market Performance
10.1.4 Gliead Business Overview
10.1.5 Gliead SWOT Analysis
10.1.6 Gliead Recent Developments
10.2 Boehringer Ingelheim
10.2.1 Boehringer Ingelheim Basic Information
10.2.2 Boehringer Ingelheim Peptide Cdmo Services Product Overview
10.2.3 Boehringer Ingelheim Peptide Cdmo Services Product Market Performance
10.2.4 Boehringer Ingelheim Business Overview
10.2.5 Boehringer Ingelheim SWOT Analysis
10.2.6 Boehringer Ingelheim Recent Developments
10.3 Vertex
10.3.1 Vertex Basic Information
10.3.2 Vertex Peptide Cdmo Services Product Overview
10.3.3 Vertex Peptide Cdmo Services Product Market Performance
10.3.4 Vertex Business Overview
10.3.5 Vertex SWOT Analysis
10.3.6 Vertex Recent Developments
10.4 Mirati Therapeutics
10.4.1 Mirati Therapeutics Basic Information
10.4.2 Mirati Therapeutics Peptide Cdmo Services Product Overview
10.4.3 Mirati Therapeutics Peptide Cdmo Services Product Market Performance
10.4.4 Mirati Therapeutics Business Overview
10.4.5 Mirati Therapeutics Recent Developments
10.5 AMPAC
10.5.1 AMPAC Basic Information
10.5.2 AMPAC Peptide Cdmo Services Product Overview
10.5.3 AMPAC Peptide Cdmo Services Product Market Performance
10.5.4 AMPAC Business Overview
10.5.5 AMPAC Recent Developments
10.6 Pfizer
10.6.1 Pfizer Basic Information
10.6.2 Pfizer Peptide Cdmo Services Product Overview
10.6.3 Pfizer Peptide Cdmo Services Product Market Performance
10.6.4 Pfizer Business Overview
10.6.5 Pfizer Recent Developments
10.7 Polypeptide
10.7.1 Polypeptide Basic Information
10.7.2 Polypeptide Peptide Cdmo Services Product Overview
10.7.3 Polypeptide Peptide Cdmo Services Product Market Performance
10.7.4 Polypeptide Business Overview
10.7.5 Polypeptide Recent Developments
10.8 Bachem
10.8.1 Bachem Basic Information
10.8.2 Bachem Peptide Cdmo Services Product Overview
10.8.3 Bachem Peptide Cdmo Services Product Market Performance
10.8.4 Bachem Business Overview
10.8.5 Bachem Recent Developments
10.9 Merck
10.9.1 Merck Basic Information
10.9.2 Merck Peptide Cdmo Services Product Overview
10.9.3 Merck Peptide Cdmo Services Product Market Performance
10.9.4 Merck Business Overview
10.9.5 Merck Recent Developments
10.10 Asymchem
10.10.1 Asymchem Basic Information
10.10.2 Asymchem Peptide Cdmo Services Product Overview
10.10.3 Asymchem Peptide Cdmo Services Product Market Performance
10.10.4 Asymchem Business Overview
10.10.5 Asymchem Recent Developments
10.11 Zhejiang Jiuzhou Pharmaceutical
10.11.1 Zhejiang Jiuzhou Pharmaceutical Basic Information
10.11.2 Zhejiang Jiuzhou Pharmaceutical Peptide Cdmo Services Product Overview
10.11.3 Zhejiang Jiuzhou Pharmaceutical Peptide Cdmo Services Product Market Performance
10.11.4 Zhejiang Jiuzhou Pharmaceutical Business Overview
10.11.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments
10.12 Sinopep
10.12.1 Sinopep Basic Information
10.12.2 Sinopep Peptide Cdmo Services Product Overview
10.12.3 Sinopep Peptide Cdmo Services Product Market Performance
10.12.4 Sinopep Business Overview
10.12.5 Sinopep Recent Developments
10.13 Frontier Biotechnologies
10.13.1 Frontier Biotechnologies Basic Information
10.13.2 Frontier Biotechnologies Peptide Cdmo Services Product Overview
10.13.3 Frontier Biotechnologies Peptide Cdmo Services Product Market Performance
10.13.4 Frontier Biotechnologies Business Overview
10.13.5 Frontier Biotechnologies Recent Developments
10.14 JYMed
10.14.1 JYMed Basic Information
10.14.2 JYMed Peptide Cdmo Services Product Overview
10.14.3 JYMed Peptide Cdmo Services Product Market Performance
10.14.4 JYMed Business Overview
10.14.5 JYMed Recent Developments
10.15 Chengdu Shengnuo Biotechnology
10.15.1 Chengdu Shengnuo Biotechnology Basic Information
10.15.2 Chengdu Shengnuo Biotechnology Peptide Cdmo Services Product Overview
10.15.3 Chengdu Shengnuo Biotechnology Peptide Cdmo Services Product Market Performance
10.15.4 Chengdu Shengnuo Biotechnology Business Overview
10.15.5 Chengdu Shengnuo Biotechnology Recent Developments
10.16 Shanghai Soho-Yiming Pharmaceuticals
10.16.1 Shanghai Soho-Yiming Pharmaceuticals Basic Information
10.16.2 Shanghai Soho-Yiming Pharmaceuticals Peptide Cdmo Services Product Overview
10.16.3 Shanghai Soho-Yiming Pharmaceuticals Peptide Cdmo Services Product Market Performance
10.16.4 Shanghai Soho-Yiming Pharmaceuticals Business Overview
10.16.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
10.17 Chinese Peptide Company
10.17.1 Chinese Peptide Company Basic Information
10.17.2 Chinese Peptide Company Peptide Cdmo Services Product Overview
10.17.3 Chinese Peptide Company Peptide Cdmo Services Product Market Performance
10.17.4 Chinese Peptide Company Business Overview
10.17.5 Chinese Peptide Company Recent Developments
10.18 Ambio Pharmaceuticals
10.18.1 Ambio Pharmaceuticals Basic Information
10.18.2 Ambio Pharmaceuticals Peptide Cdmo Services Product Overview
10.18.3 Ambio Pharmaceuticals Peptide Cdmo Services Product Market Performance
10.18.4 Ambio Pharmaceuticals Business Overview
10.18.5 Ambio Pharmaceuticals Recent Developments
10.19 Zhejiang Peptites Biotech
10.19.1 Zhejiang Peptites Biotech Basic Information
10.19.2 Zhejiang Peptites Biotech Peptide Cdmo Services Product Overview
10.19.3 Zhejiang Peptites Biotech Peptide Cdmo Services Product Market Performance
10.19.4 Zhejiang Peptites Biotech Business Overview
10.19.5 Zhejiang Peptites Biotech Recent Developments
10.20 STA Pharmaceutical
10.20.1 STA Pharmaceutical Basic Information
10.20.2 STA Pharmaceutical Peptide Cdmo Services Product Overview
10.20.3 STA Pharmaceutical Peptide Cdmo Services Product Market Performance
10.20.4 STA Pharmaceutical Business Overview
10.20.5 STA Pharmaceutical Recent Developments
11 Peptide Cdmo Services Market Forecast by Region
11.1 Global Peptide Cdmo Services Market Size Forecast
11.2 Global Peptide Cdmo Services Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Peptide Cdmo Services Market Size Forecast by Country
11.2.3 Asia Pacific Peptide Cdmo Services Market Size Forecast by Region
11.2.4 South America Peptide Cdmo Services Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Peptide Cdmo Services by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Peptide Cdmo Services Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Peptide Cdmo Services by Type (2026-2033)
12.1.2 Global Peptide Cdmo Services Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Peptide Cdmo Services by Type (2026-2033)
12.2 Global Peptide Cdmo Services Market Forecast by Application (2026-2033)
12.2.1 Global Peptide Cdmo Services Sales (K Units) Forecast by Application
12.2.2 Global Peptide Cdmo Services Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key Findings
